These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6667926)

  • 21. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML
    Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
    Southan C; Kehl M; Henschen A; Lane DA
    Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.
    Southan C; Lane DA; Knight I; Ireland H; Bottomley J
    Biochem J; 1985 Aug; 229(3):723-30. PubMed ID: 4052020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains.
    Miyata T; Terukina S; Matsuda M; Kasamatsu A; Takeda Y; Murakami T; Iwanaga S
    J Biochem; 1987 Jul; 102(1):93-101. PubMed ID: 3667568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Substitution of A alpha arginine-16 by cysteine in two abnormal fibrinogens (Kawaguchi and Osaka I)].
    Matsuda M; Terukina S; Miyata T; Iwanaga S; Kasamatsu A; Takeda Y
    Rinsho Byori; 1987 Sep; Spec No 73():161-9. PubMed ID: 3481412
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH; Gram J; Bruhn HD; Witt I
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers].
    Saeki E; Matsuda M; Ichinose A; Samejima Y; Kasamatsu A; Ara R; Mitsuno K; Kihara T; Hara Y
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1229-35. PubMed ID: 4072586
    [No Abstract]   [Full Text] [Related]  

  • 31. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
    Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
    J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.
    Yamazumi K; Terukina S; Matsuda M; Kanbayashi J; Sakon M; Tsujinaka T
    Surg Today; 1993; 23(1):45-50. PubMed ID: 8461606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
    Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
    Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
    Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen giessen I: a congenital homozygously expressed dysfibrinogenemia with A alpha 16 Arg----His substitution.
    Alving BM; Henschen AH
    Am J Hematol; 1987 Aug; 25(4):479-82. PubMed ID: 3618591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of delayed fibrinopeptide-A release on fibrin structure. Studies of an abnormal fibrinogen.
    Carr ME; Qureshi GD
    J Biol Chem; 1987 Nov; 262(32):15568-74. PubMed ID: 3680212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.